Biotech Startups

BioPhenoMA develops a protein detection technology platform based on its proprietary TN-cyclon (improved enzyme cycling method) to quantify ultra-trace amounts of proteins in real biological samples while preserving their structure and localization. It targets biomedical and life-science researchers analyzing the mechanisms of biological phenomena.

1 investor

BioPhy builds a suite of modular AI tools for pharmaceutical companies, automating quality, compliance, manufacturing, and supply-chain tasks such as SOP–regulation gap analysis, document consolidation, and IQ/OQ/PQ validation. Its platform targets pharma quality operations, manufacturing, and validation teams to reduce manual documentation and review work.

1 investor

Biopremier supplies molecular diagnostic products and laboratory equipment, including real-time PCR and ELISA test kits for detecting pathogens, mycotoxins, and food adulteration in food, animal feed, and environmental and veterinary samples. It also provides laboratory instruments and services such as biosafety cabinets, plate readers, and molecular biology lab setup and training for food safety and veterinary diagnostics.

1 investor

Bioprex Medical develops antibacterial coatings for medical devices to prevent infections by inhibiting biofilm formation on device surfaces. The company serves healthcare providers and medical device manufacturers seeking to reduce device-associated infection risk.

1 investor

BiopSense develops an automated cartridge for extracting cell-free nucleic acids (DNA, RNA, cells, proteins) from large blood volumes without centrifugation, aimed at simplifying liquid biopsy sample preparation and transport for cancer diagnostics and monitoring. It serves oncology clinical laboratories and healthcare providers to enable non-invasive cancer treatment monitoring and personalization.

1 investor

Bioptamers develops personalized precision cancer therapies that identify targetable molecular signatures unique to each patient's tumor and deliver therapeutics directly to cancer cells. Its target-agnostic platform aims to treat primary tumors and metastatic disease while reducing off-target effects.

1 investor

Bondwell Technologies develops protein-based materials for bioprocessing and biomanufacturing applications. The company's technology, discovered by academic researchers, is being scaled for commercial use in pharmaceutical, medical device, and regenerative medicine sectors.

1 investor

1 investor

Bioretec develops fully biodegradable orthopedic implants for fracture healing and orthopedic surgery, including the RemeOs product line based on magnesium alloy and the Activa line of bioabsorbable implants. The company serves orthopedic surgeons and patients globally across approximately 40 countries.

1 investor

Bios Partners is a venture capital firm focused on life sciences and biotech investments, providing diligence and portfolio support for clinical-stage and precision medicine companies. The firm combines deep expertise in drug development, pharmaceutical R&D, and equity research for healthcare institutions.

1 investor

Bioscibex develops SW1NGO, a single-use system that automates the seed train in biologics manufacturing by scaling directly from 30 mL up to 30 L in one step, eliminating manual cell passaging and reducing contamination risks. It targets biopharma companies and CDMOs involved in upstream process development and manufacturing.

1 investor

BioSeek builds an AI platform for drug discovery that unifies fragmented biological sources—literature, patents, clinical, and chemistry data—into a connected knowledge graph, with specialist agents that reason across it from disease biology to safety-screened molecules. The software is deployed inside a customer's own infrastructure so proprietary data and tools join the private graph without leaving their environment, targeting enterprise pharma and biotech research teams.

1 investor

BioSenic develops products and medical devices for inflammatory diseases and bone disorders in the field of regenerative and immune medicine. The company focuses on clinical development for these therapeutic areas.

1 investor

Sens.bio manufactures a portable device for on-site detection of mycotoxins in grains and animal feed using a test cartridge and mobile app data analysis. The device serves agronomic researchers, farms, and grain storage operators to assess crop and feed contamination quickly without laboratory analysis.

1 investor

Biosens8 develops wearable health monitoring devices that track physiological markers including cortisol and women's health metrics. The company serves health-conscious consumers interested in personal biometric monitoring.

1 investor

Biosergen is a biotech company developing antifungal drugs to treat life-threatening invasive fungal infections in immunocompromised patients, including those with AIDS, cancer, and transplant recipients. Its lead drug candidate, BSG005, is a polyene macrolide invented at the Norwegian University of Science and Technology with SINTEF, and the company is listed on Nasdaq First North Growth Market in Stockholm.

1 investor

Biosidus is a biotechnology company focused on applying biotech to human health, developing and commercializing therapeutic products. Founded in 1983, it serves healthcare markets and pursues business internationally, including North African countries such as Algeria, Tunisia, and Libya.

1 investor

Biosortia develops an aquatic natural products drug discovery platform, leveraging marine organisms to identify pharmaceutical compounds for various therapeutic areas.

1 investor

BioSpeedia is a biotechnology company that develops and produces rapid lateral-flow diagnostic tests for infectious diseases, including tests for bacterial meningitis and SARS-CoV-2. A spin-off from the Institut Pasteur, it distributes its diagnostic products worldwide through affiliated entities.

1 investor

Biospring is an investment firm that partners with technology-enabled, EBITDA-positive pharma services businesses focused on manufacturing and clinical trial services. Its portfolio companies produce and support the supply chain for complex medicines such as biologics, cell therapies, and peptides, and modernize clinical trial site operations, patient recruitment, and related technology for the life sciences industry.

1 investor

Biosurfit develops point-of-care diagnostic instruments and tests for blood analysis, including devices for measuring C-reactive protein, blood counts, and HbA1c levels. The company serves hospitals, clinics, and mobile health units across Europe, and has expanded into contract manufacturing services for diagnostic and medical device companies.

1 investor

BioSurplus buys, sells, sources, redeploys, and auctions used life-science laboratory equipment, helping companies recover capital from idle assets and helping buyers access quality instruments. It serves life-science companies and researchers in the secondary market for lab equipment.

1 investor

Biosynthetic Technologies develops innovative solutions in R&D and operations for sustainability-focused applications. The company serves markets requiring supply chain and operational expertise.

1 investor

Biotech Finances is a French-language news and analysis publication covering the biotech, pharma and medtech industries, focusing on financing, mergers and acquisitions, clinical developments and listed biotech valuations. It publishes articles, weekly briefings, a "Biotech Express" news feed and an industry events agenda.

1 investor